Prostatitis: US perspective

International Journal of Antimicrobial Agents

Volumn 11, Issue 3-4, 1999, Pages 205-211

  Schaeffer, A J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Pelvic pain; Prostatitis; Urinary tract infection

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PRAZOSIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TERAZOSIN; TETRACYCLINE; TRIMETHOPRIM;

CHLAMYDIA TRACHOMATIS; CONFERENCE PAPER; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TISSUE LEVEL; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SECRETION; PROSTATITIS; QUALITY OF LIFE; SYMPTOMATOLOGY; TRANSURETHRAL RESECTION;

EID: 0032898907     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00046-1     Document Type: Conference Paper

References (45)

1. Lipsky BA. Urinary tract infection in men. Ann Intern Med 1989;110:138-50.
2. Roberts RO, Lieber MM, Bostwick DG, et al. A review of clinical and pathological prostatitis syndromes. Urology 1997;49(6):809-21.
3. Kneger JN, Egan KJ, Ross SO, et al. Chronic pelvic pains represent the most prominent urogenital symptoms of 'chronic prostatitis'. Urology 1996;48(5):715-22.
4. Drach GW, Fair WR, Meares EM, et al. Classification of benign diseases associated with prostatic pain: Prostatitis or prostatodynia? (Letter). J Urol 1978;120:226.
5. Doble A, Carter SS. Ultrasonographic findings in prostatitis. Urol Clin North Am 1989;16:763-72.
6. Bude R, Bree RL, Adler RS, et al. Transrectal ultrasound appearance of granulomatous prostatitis. J Ultrasound Med 1990;9:677-80.
7. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968;5:492-518.
8. Meares EM Jr. Prostatitis. Med Clin North Am 1991;75:405-24.
9. Meares EM Jr. Prostatitis: Review of pharmacokinetics and therapy. Rev Infect Dis 1982;4:475-83.
10. Schaeffer AJ. Multiclinic study of norfloxacin for treatment of urinary tract infections. Am J Med 1987;82(Suppl 6B):53-58.
11. Sabbaj J, Hoagland VL, Shih WJ. Multiclinic comparative study of norfloxacin and trimethoprimsulfamethoxazole for treatment of urinary tract infections. Antimicrob Agents Chemother 1985;27:297-301.
12. Downs J, Andriole VT, Ryan JL. In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1982;21:670-2.
13. Wolfson JS, Hooper DC. The fluoroquinolones: Structures, mechanism of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 1985;28:581-6.
14. Hooper DC, Wolfson JS. The fluoroquinlones: Pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother 1985;28:716-21.
15. Bergeron MD, et al. Norfloxacin penetration into human renal and prostatic tissues. Antimicrob Agents Chemother 1985;28:349-50.
16. Bologna M, Vaggi L, Flammini D, et al. Norfloxacin in prostatitis: Correlation between HPLC tissue concentration and clinical results. Drugs Exp Clin Res 1985;11:95-100.
17. Dan M, Golomb J, Gorea A, et al. Penetration of norfloxacin into human prostatitic tissue following single-dose oral administration. Chemotherapy 1987;33:240-2.
18. Hoogkamp-Korstanje JAA, van Oort HJ, Schipper JJ, et al. Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens. J Antimicrob Chemother 1984;14:641-5.
19. Boerama JBJ, Dalhoff A, Debruyne FMY. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration. Chemotherapy 1985;31:13-8.
20. Dan M, Golomb J, Gorea A, et al. Concentration of ciprofloxacin in human prostatic tissue after oral administration. Antimicrob Agents Chemother 1986;30:88-9.
21. Scully BE. Pharmacology of the fluoroquinolones. Urology 1990;35(Suppl):8-11.
22. Sabbaj J, Hoagland VL, Cook T. Norfloxacin versus cotrimoxazole in the treatment of recurring urinary tract infection in men. Scand J Infect Dis 1986;48(Suppl):48-53.
23. Childs SJ. Ciprofloxacin in treatment of chronic bacterial prostatitis. Urology 1990;(Suppl)35:15-18.
24. Guibert J, Destre D, Konopka C, et al. Ciprofloxacin in the treatment of urinary tract infection due to Enterobacteriaceae. Eur J Clin Microbiol Infect Dis 1986;5:247-8.
25. Langemeyer TNM, Ferwerda WHH, Hoogkamp-Korstanje JAA, et al. Treatment of chronic bacterial prostatitis with ciprofloxacin. Pharm Weekbl Sci 1987;9(Suppl):S78-81.
26. Remy G, Rouger C, Chavanet P, et al. Use of Ofloxacin for Prostatitis (abstract). RWJPRI, 1988.
27. Weidner W, Schiefer HG, Dalhoff A. Treatment of chronic bacterial prostatitis with ciprofloxacin, results of a one year follow-up study. Am J Med 1987;82:(Suppl 41):280-283.
28. Schaeffer AJ, Darras FS. The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. J Urol 1990;144:690-3.
29. Meares EM Jr. Prostatitis syndromes: New perspectives about old woes. J Urol 1980;123:141-7.
30. McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol 1968;49:347-57.
31. Blalock NJ. Anatomic factors in prostatitis. Br J Urol 1974;46:47-54.
32. Berger RE, Krieger JN, Kessler D, et al. Case control study of men with suspected chronic idiopathic prostatitis. J Urol 1989;141:328-31.
33. Mardh P-A, Collen S. Search for uro-genital tract infections in patients with symptoms of prostatitis. Studies on aerobic and strictly anaerobic bacteria, mycoplasma, fungi, trichomonads and viruses. Scand J Urol Nephrol 1975;9:8-16.
34. Mardh P-A, Ripa KT, Collen S, et al. Role of Chlamydia trachomatis in non-acute prostatitis. Br J Vener Dis 1978;54:330-4.
35. Meares EM. Bacterial prostatitis versus "prostatosis": A clinical and bacteriological study. J Am Med Assoc 1973;224:1372-5.
36. Brunner H, Weidner W, Schiefer HG. Studies of the role Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. J Infect Dis 1983;147:807-13.
37. Poletti F, Medici MC, Menozzi MG, et al. Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis. J Urol 1985;134:691-3.
38. Schacter J. Is Chlamydia trachomatis a cause of prostatitis (editorial)? J Urol 1985;134:711.
39. Weidner W, Schiefer HG, Krauss H. Role of Chlamydia trachomatis and Mycoplasma in chronic prostatitis (Review). Urol Int 1988;43:167-73.
40. Abdelatif OM, Chandler FW, McGuire BS Jr. Chlamydia trachomatis in chronic abacterial prostatitis: Demonstration by colorimetric in situ hybridization. Hum Pathol 1991;22:41-4.
41. Shortliffe LMD, Wehner N. The characterization of bacterial and nonbacterial prostatitis by prostatic immunoglobulins. Medicine 1986;65:399-414.
42. Shortliffe LMD, Elliott KM, Sellers RG, et al. Measurement of chlamydial and ureaplasma antibodies in serum and prostatic fluid of men with nonbacterial prostatitis (abstract). J Urol 1985;133(4 Pt 2):276A.
43. Barbalias GA, Meares EM, Sant GR. Prostatodynia: Clinical and urodynamic characteristics. J Urol 1983;130:514-7.
44. Barbalias GA. Prostatodynia or painful male urethral syndrome? Urology 1990;361:146-53.
45. Schaeffer AJ, Wendel EF, Dunn JK, et al. Prevalence and significance of prostatic inflammation. J Urol 1981;125:215-9.